Data as of Oct 17
| +0.47 / +3.97%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 29.00 and a low estimate of 18.00. The median estimate represents a +54.35% increase from the last price of 12.31.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.